Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Contrast-induced Nephropathy
NCT02489240Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in contrast-induced nephropathy (CIN) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Prevalence of Contrast-induced Nephropathy. Status: unknown.
02
Drugs
vitamin d
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02489240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489240.